BUB bubs australia limited

China ended up better than expected, so it is good to see they...

  1. 4,852 Posts.
    lightbulb Created with Sketch. 2033
    China ended up better than expected, so it is good to see they finally made some progress there. Still can't help but feel it is being unnecessarily limited by focusing more on O2O rather than CBEC.

    Unfortunately the bigger issue is that they have still not been able to get their costs down. I think with this update, a capital raise in the next 6-12 months is highly likely.

    I'm not a fan of them claiming that the higher than anticipated cash burn was 'demand-driven'. At some point you have to convert the demand into profitability, or else you are doing something wrong. When the next cash raise happens you can bet it will be sold to the market as 'demand driven' as well.

    I think the main issue with cost is probably USA. Yes it contributes revenue and gives the veneer of success but how much are they spending on marketing, shipping and logistics, how many more FDA 'one-offs' are coming down the pipeline etc.
    Last edited by werdplaya58: 29/07/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
17.0¢
Change
-0.005(2.86%)
Mkt cap ! $151.8M
Open High Low Value Volume
17.0¢ 17.5¢ 17.0¢ $82.49K 485.2K

Buyers (Bids)

No. Vol. Price($)
10 382111 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 609003 11
View Market Depth
Last trade - 16.10pm 18/07/2025 (20 minute delay) ?
BUB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.